News
Prota, Chr. Hansen partner on peanut allergy
25 Apr 2018Prota Therapeutics has partnered with Chr. Hansen to assess what is said to be the world’s best documented probiotic strain, LGG, in a Phase III clinical trial to develop a treatment for peanut allergy.
![Prota, Chr. Hansen partner on peanut allergy](/img/ingnet-logo.png)
Prota Therapeutics, the developer of oral immunotherapies to treat food allergies, has partnered with Chr. Hansen. The partnership will assess what is said to be the world’s best documented probiotic strain, LGG, in a Phase III clinical trial to develop a treatment for peanut allergy.
Approximately 220-250 million people globally suffer from food allergies, an increase of 350% over the past 20 years. The economic impact for treatment of food allergies in the US has been estimated at US$24.8 billion per year.Peanut allergy is the most common cause of anaphylaxis, a life-threatening allergic reaction, and one of the most common causes of death from food allergy2. More than 3 million Americans suffer from peanut allergy resulting in a global peanut allergy therapeutics market estimated to reach more than US$10 billion by 2025.Prota Therapeutics says it is pioneering a new form of oral immunotherapy treatment. It combines Chr. Hansen’s specifically formulated LGG4 probiotic strain, Lactobacillus rhamnosus, with targeted doses of proprietary formulations of peanut protein. The treatment is designed to reprogram the immune system’s response to peanuts and eventually develop tolerance.Building upon earlier trials conducted at the Murdoch Children’s Research Institute, Prota Therapeutics says it is progressing towards a large-scale Phase III clinical trial, under a US Investigational New Drug Application (IND). The aim is to commercialize a medicinal product using a new pharmaceutical grade therapeutic dosage form for treating peanut allergy, and to explore indications for treating other food allergies."An effective therapy to treat peanut allergies is now a realistic target. Chr. Hansen is the ideal partner for us in this next step, both as the owner of one of the key components in the therapeutic product – LGG – and as a leading expert in microbial solutions. Chr. Hansen has demonstrated the capability to deliver a pharmaceutical quality product that can be regulated as a biological therapeutic product. Together with our proprietary peanut protein formulation, we aim to progress this through to commercialization of a treatment for peanut allergies,” said Dr. Suzanne Lipe, CEO at Prota Therapeutics.Numerous studies have highlighted the therapeutic potential of specific bacteria in preventing and treating metabolic, gastrointestinal and other diseases. Investigating specific bacteria for the treatment of food allergies is an area that has recently gained momentum.Having produced LGG for more than 10 years before fully acquiring LGG from Valio in 2016, this new partnership is an example of how Chr. Hansen’s focus on industry leading product quality and clinical documentation can expand the potential of the LGG probiotic strain into a new breakthrough area.Christian Barker, Executive Vice President, Health & Nutrition at Chr. Hansen, said: “Chr. Hansen has the ability to maximize the value of a probiotic strain through our deep experience in microbial process development and formulation, our focus on quality, and our global reach. The partnership with Prota Therapeutics is part of our strategy to become the partner of choice for companies wanting to develop new generations of therapeutic microbes.”Related news
![Consumers lack confidence in Australasian food labelling and ‘fake’ meat](/47/pdcnewsitem/12/48/19/th124819.png)
Consumers lack confidence in Australasian food labelling and ‘fake’ meat
5 Jul 2024
Australian and New Zealand consumers are concerned about foodborne illnesses and do not trust cell-cultured meat, according to a survey by Food Safety Australia and New Zealand (FSANZ).
Read more![Nestlé launches GLP-1 Nutrition initiative](/47/pdcnewsitem/12/48/15/th124815.png)
Nestlé launches GLP-1 Nutrition initiative
4 Jul 2024
Nestlé Health Science has introduced GLP-1 Nutrition, an initiative to support consumers during their weight loss efforts, building on the recent launch of its Vital Pursuit product range. “Nutrition, science, and wellness must merge – not collide,” it...
Read more![Rethinking funding for food technology](/47/pdcnewsitem/12/47/76/th124776.png)
Rethinking funding for food technology
28 Jun 2024
The landscape of foodtech investment is evolving. With the need for long-term investment perspectives, what are the most effective strategies driving the next wave in foodtech innovation?
Read more![Chinese Gen Z consumers hungry for alternative proteins](/47/pdcnewsitem/12/47/70/th124770.png)
Chinese Gen Z consumers hungry for alternative proteins
27 Jun 2024
China’s Gen Z could be at the forefront of a dietary shift, with younger consumers increasingly open to and curious about alternative proteins. With the right strategies to address their concerns and highlight the benefits, the alternative protein mark...
Read more![Will ASEAN harmonise food marketing rules for children?](/47/pdcnewsitem/12/47/17/th124717.png)
Will ASEAN harmonise food marketing rules for children?
21 Jun 2024
ASEAN Health Ministries and UNICEF release new guidelines on how food and beverage brands should market their products to children to protect them from harm.
Read more![Adventurous US consumers eager for ‘swicy’ flavours](/47/pdcnewsitem/12/47/01/th124701.png)
Adventurous US consumers eager for ‘swicy’ flavours
19 Jun 2024
US manufacturers and marketers are tapping into the adventurer consumer persona and enhancing their products with elevated and diverse ‘swicy’ flavours.
Read more![Scientists use digital PCR technology to ensure food safety](/47/pdcnewsitem/12/46/44/th124644.png)
Scientists use digital PCR technology to ensure food safety
18 Jun 2024
Researchers are applying digital polymerase chain reaction (PCR) technology to accurately identify and quantify allergens in foods and adulteration in meat.
Read more![Fibre-filled bread leads health-conscious baked buys in Asia](/47/pdcnewsitem/12/46/45/th124645.png)
Fibre-filled bread leads health-conscious baked buys in Asia
17 Jun 2024
Value revolves around better-for-you bakery claims and nutritious seed-rich loaves as consumers seek less sugar and more fibre from their baked goods, according to Mintel.
Read more![Savvy shoppers choose savings despite lower inflation](/47/pdcnewsitem/12/46/43/th124643.png)
Savvy shoppers choose savings despite lower inflation
12 Jun 2024
Consumers remain cautious about spending, despite global drops in inflation and the UK recording its lowest inflation levels in recent years.
Read more![Brazilian study finds high levels of mycotoxins in flour and rice](/47/pdcnewsitem/12/45/94/th124594.png)
Brazilian study finds high levels of mycotoxins in flour and rice
10 Jun 2024
For the first time, scientists in Brazil used biomarkers to analyse the risk of mycotoxins in consumers’ diets, finding that some exceed maximum permitted levels.
Read more